Karin Shanahan, Executive Vice President and Chief Supply Chain and Operations Officer at Bristol Myers Squibb, filed a Form 4 on November 3, 2026, disclosing transactions in Bristol Myers Squibb common stock on November 1, 2026.

Key Highlights

  • RSU vesting: 6,281 restricted stock units vested on November 1, 2026, representing one-third of an RSU grant originally made on November 1, 2024, acquired at $0 per share.
  • Tax withholding: 3,213 shares were withheld at $62.48 per share to cover taxes upon vesting of the awards.
  • Remaining RSUs: Following the transactions, 6,281 restricted stock units remain outstanding, with the next vesting date of November 1, 2027.
  • Direct holdings after transactions: Shanahan directly holds 28,956 shares of Bristol Myers Squibb common stock following the reported transactions.
  • Indirect holdings: Shanahan also holds 1,457.717 shares indirectly through the BMS Savings and Investment Program, based on a recent 401(k) plan statement.
  • Issuer: Bristol Myers Squibb Co, trading on NYSE:BMY.

Shanahan RSU Vesting and Tax Withholding Details - November 2026

According to the Form 4 filed with the SEC on November 3, 2026, Karin Shanahan, EVP and Chief Supply Chain and Operations Officer at Bristol Myers Squibb, reported two transactions in the company's common stock ($0.10 par value) on November 1, 2026. The first was the vesting of 6,281 restricted stock units (transaction code M), which were acquired at a price of $0 per share. The filing states this represents one-third of an RSU grant originally awarded on November 1, 2024.

The second transaction involved the disposition of 3,213 shares (transaction code F) at a price of $62.48 per share. The filing describes these as "shares withheld for payment of taxes upon vesting of awards." Following both transactions, Shanahan directly holds 28,956 shares of Bristol Myers Squibb common stock.

In addition to direct holdings, the filing discloses that Shanahan indirectly holds 1,457.717 shares through the BMS Savings and Investment Program, described as based on a recent 401(k) plan statement. Regarding the remaining derivative securities, the filing shows 6,281 restricted stock units still outstanding after the vesting event, with an expiration date of November 1, 2027. The filing notes that each restricted stock unit converts into one share of common stock upon vesting, and that the units vest in three equal annual installments beginning November 1, 2025. The form was signed by Amy Fallone as attorney-in-fact for Karin Shanahan.

What Was Disclosed

The filing disclosed the vesting of 6,281 RSUs and the tax-related withholding of 3,213 shares at $62.48 on November 1, 2026, leaving Shanahan with 28,956 directly held shares and 6,281 RSUs still outstanding.